Strober, Bruce
van de Kerkhof, Peter C. M.
Callis Duffin, Kristina
Poulin, Yves
Warren, Richard B.
de la Cruz, Claudia
van der Walt, Joelle M.
Stolshek, Bradley S.
Martin, Mona L.
de Carvalho, Andre V. E.
Funding for this research was provided by:
Amgen
Article History
First Online: 21 June 2019
Compliance with Ethical Standards
:
: This study was sponsored by Immunex, a wholly owned subsidiary of Amgen Inc.
: <i>B. Strober</i> serves as a consultant for AbbVie Inc., Almirall, S.A., Amgen Inc., AstraZeneca, Celgene Corp., Dermira, Inc., Janssen Global Services, LLC, LEO Pharma Inc., Eli Lilly & Co., GlaxoSmithKline, plc, Medac Pharma Inc., Menlo Therapeutics, Novartis AG, Pfizer Inc., UCB, Sun Pharma, and Ortho Dermatologics/Valeant Pharmaceuticals; is an investigator for AbbVie Inc., Boehringer Ingelheim, Celgene Corp., Eli Lilly & Co., Galderma S.A., Janssen Global Services, LLC, Merck & Co., Inc., and Sienna Biopharmaceuticals; serves as Scientific Director for the Corrona Psoriasis Registry; and has received grant support to the University of Connecticut Fellowship Program from AbbVie Inc. and Janssen Global Services, LLC. <i>P.C.M. van de Kerkhof</i> is a consultant for Abbott Laboratories, Almirall, S.A., Amgen Inc., Celgene Corp., Centocor, Eli Lilly & Co., Galderma S.A., Janssen-Cilag, LEO Pharma Inc., Mitsubishi Tanabe Pharma America, Inc., Novartis AG, Pfizer Inc., Koninklijke Philips N.V., and Sandoz International GmbH; and is an investigator for AbbVie Inc., Amgen Inc., Basilea Pharmaceutica Ltd., Eli Lilly & Co., Janssen-Cilag, LEO Pharma Inc., Koninklijke Philips N.V., and Pfizer Inc. <i>K. Callis Duffin</i> has received research grants from AbbVie Inc., Amgen Inc., Celgene Corp., Eli Lilly & Co., Janssen Global Services, LLC, Novartis AG, Pfizer Inc., Sienna Biopharmaceuticals, and Stiefel Laboratories, Inc.; and has received consulting fees from AbbVie Inc., Amgen Inc., Celgene Corp., Eli Lilly & Co., Janssen Global Services, LLC, Novartis AG, Pfizer Inc., Sienna Biopharmaceuticals, and Stiefel Laboratories, Inc. <i>Y. Poulin</i> has received research grants from Boehringer Ingelheim, Bristol-Myers Squibb, Celgene Corp., Eli Lilly & Co., Galderma S.A., GlaxoSmithKline plc, LEO Pharma Inc., MedImmune, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron, and UCB; and serves on speakers bureaus for AbbVie Inc., Amgen Inc., Eli Lilly & Co., Novartis AG, and Sanofi Genzyme. <i>R.B. Warren</i> has received research grants from AbbVie Inc., Almirall, S.A., Amgen Inc., Celgene Corp., Eli Lilly & Co., Janssen Global Services, LLC, LEO Pharma Inc., Novartis AG, Pfizer Inc., and UCB; and is a consultant for AbbVie Inc., Almirall, S.A., Amgen Inc., Boehringer Ingelheim, Celgene Corp., Eli Lilly & Co., Janssen Global Services, LLC, LEO Pharma Inc., Novartis AG, Pfizer Inc., Sanofi, XenoPort, Inc., and UCB. <i>C. de La Cruz</i> has received research grants from AbbVie Inc., Amgen Inc., Coherus Biosciences, Eli Lilly & Co., Genentech, Neovacs S.A., Novartis AG, and Pfizer Inc.; and is a consultant for AbbVie Inc., Janssen Global Services, LLC, Novartis AG, and Pfizer Inc. <i>J. van der Walt</i> has no conflicts to declare. <i>B.S. Stolshek</i> is an employee and shareholder of Amgen Inc. <i>M.L. Martin</i> is an employee of Health Research Associates, Inc., which received funding from Amgen Inc. to conduct this study. <i>A.V.E. de Carvalho</i> has received research grants from Amgen Inc. and serves on speakers bureaus for Janssen Global Services, LLC, Novartis AG, and Pfizer Inc.